SXC Health Buys Catalyst for $4.4B as Industry Consolidates

SXC Health Solutions' acquisition of Catalyst Health Solutions for $81.02 a share adds to consolidation in the pharmacy benefits space.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!